Mitochondrial depolarization and apoptosis associated with sustained activation of c-jun-N-terminal kinase in the human multiple myeloma cell line U266 induced by 2-aminophenoxazine-3-one

Molecular Medicine Reports

Volumn 2, Issue 2, 2009, Pages 199-203

  Takasaki, Akira ^a   Hanyu, Haruo ^a   Iwamoto, Toshihiko ^a   Shirato, Ken ^b   Izumi, Ryutaro ^c   Toyota, Hiroko ^a   Mizuguchi, Junichiro ^a   Miyazawa, Keisuke ^a   Tomoda, Akio ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JAPAN AEROSPACE EXPLORATION AGENCY   (Japan)

Author keywords

Apoptosis; c jun N terminal kinase activation; Mitochondrial depolarization; Phenoxazine; U266 cells

Indexed keywords

2 AMINOPHENOXAZINE 3 ONE; AMINOPHENOL DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL MEMBRANE DEPOLARIZATION; CHEMICAL STRUCTURE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOCHONDRION; MULTIPLE MYELOMA; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 69249088130     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000084     Document Type: Article

References (26)

1. Van der Heiden MG, Chandel NS, Williamson EK, Schumacker PT and Thompson CB: Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-637, 1997.
2. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997. (Pubitemid 27508237)
3. Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R and Greenberg AH: BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20: 5454-5468, 2000. (Pubitemid 30482883)
4. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
5. Herr I and Debatin K-M: Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614, 2001.
6. Shimizu S, Suzuki M, Tomoda A, Arai S, Taguchi H, Hanawa T and Kamiya S: Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria. Tohoku J Exp Med 203: 47-52, 2004. (Pubitemid 38832654)
7. Kasuga T, Tabuchi T, Shirato K, Imaizumi K and Tomoda A: Caspase-independent cell death revealed in human gastric cancer cell lines, KATO III and MKN45 treated with phenoxazine derivatives. Oncol Rep 17: 409-415, 2007.
8. Shirato K, Imaizumi, Abe A and Tomoda A: Phenoxazine derivatives induce caspase-independent cell death in human glioblastoma cell lines, A-172 and U-251 MG. Oncol Rep 17: 201-208, 2007.
9. Shirato K, Imaizumi, Abe A and Tomoda A: Effects of phenoxazines, 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one and 2-aminophenoxazine-3-one on cellular proliferation and apoptosis in human neuroblastoma cell line NB-1 cells. Biol Pharm Bull 30: 331-336, 2007.
10. Shirato K, Imaizumi K, Miyazawa K, Takasaki A, Mizuguchi J, Che X-F, Akiyama S and Tomoda A: Apoptosis induction preceded by mitochondrial depolarization in multiple myeloma cell line U266 by 2-aminophenoxazine-3-one. Biol Pharm Bull 31: 62-67, 2008.
11. Weston CR and Davis RJ: The JNK signal transduction pathway. Curr Opin Genet Dev 12: 14-21, 2002.
12. Tsuruta F, Sunayama J, Mori Y, Hattori S, Shimizu S, Tsujimoto Y, Yoshioka K, Masuyama N and Gotoh Y: JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 23: 1889-1899, 2004.
13. Kajiguchi T, Yamamoto K, Iida S, Ueda R, Emi N and Naoe T: Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines. Cancer Sci 97: 540-545, 2006. (Pubitemid 43811597)
14. Takata R, Fukasawa S, Hara T, Nakajima H, Yamashina A, Yanase N and Mizuguchi J: Cerivastatin-induced apoptosis of human aortic smooth muscle cells through partial inhibition of basal activation of extracellular signal-regulated kinases. Cardiovasc Pathol 13: 41-48, 2004. (Pubitemid 38169465)
15. Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2002.
16. Chen YR, Wang X, Templeton D, Davis RJ and Tan T-H: The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 271: 31929-31936, 1996. (Pubitemid 26422216)
17. Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang V, Siddik ZH, Mills GB and Claret FX: Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. J Biol Chem 278: 19245-19256, 2003. (Pubitemid 36799316)
18. Lamb JA, Ventura JJ, Hess P, Flavell RA and Davis RJ: Jun D mediates survival signaling by the JNK signal transduction pathway. Mol Cell 11: 1479-1489, 2003. (Pubitemid 36776535)
19. Koyama T, Minami T, Koyama T, Imakiire A, Yamamoto K, Toyota H and Mizuguchi J: Apoptosis induced by chemotherapeutic agents involves c-Jun N-terminal kinase activation in sarcoma cell lines. J Orthopaed Res 24: 1153-1162, 2006. (Pubitemid 43870877)
20. Wang X: The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933, 2001.
21. Tsuruta F, Masuyama N and Gotoh Y: The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem 277: 14040-14047, 2002. (Pubitemid 34968013)
22. Tsujimoto Y and Shimizu S: Bcl-2 family: life-or-death switch. FEBS Lett 466: 6-10, 2000.
23. Sunayama J, Tsuruta F, Masuyama N and Gotoh Y: JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3 proteins. J Cell Biol 170: 295-304, 2005. (Pubitemid 41043811)
24. Hendrich AB, Stanczak K, Komorowska M, Motohashi N, Kawase M and Michalak K: A study on the perturbation of model lipid membranes by phenoxazines. Biorg Med Chem 14: 5948-5954, 2006. (Pubitemid 44080585)
25. Bendic C and Volanschi E: Molecular modeling of the interaction of some phenoxazone-antitumoral drugs with DNA. Internet Electro J Mol Des 5: 320-330, 2006.
26. Hollstein U: Actinomycin, chemistry and mechanism of action. Chem Rev 74: 625-652, 1974.